IP Library Granted Patent US 10,532,141
Granted Patent B2
US 10,532,141 · App. 15/840,102 · Granted Jan 14, 2020

Systems and methods for multifunctional volumetric fluid control

Inventors: Thomas E. Meyer (Stillwater, MN); David B. Lura (Maple Grove, MN); Bryant J. Pudil (Plymouth, MN); Martin T. Gerber (Maple Grove, MN)
Assignee: Medtronic, Inc.
A61M1/1621A61M1/16A61M1/1601A61M1/169A61M1/1652A61M1/1656A61M1/1696A61M1/3413A61M1/3627A61M1/3643A61M1/165A61M1/3437A61M1/3626A61M2209/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,532,141
App. No.
15/840,102
Granted
Jan 14, 2020
Kind
B2
Abstract

Systems and methods for controlling fluid movement and volumes of fluid between a subject and a controlled compliant flow path. The controlled compliant flow path has a means for selectively metering in and metering out fluid from the controlled compliant flow path. An extracorporeal flow path is in fluid communication with the controlled compliant flow path across a semi-permeable membrane where the extracorporeal flow path has a first terminal end and a second terminal end.

Claims (26)

1. A system for performing any one of hemodialysis, hemodiafiltration, hemofiltration, comprising:

a controlled compliant flow path comprising a dialyzer;

at least a first pump in fluid communication with the controlled compliant flow path; a common reservoir in fluid communication with the first pump, wherein the common reservoir contains any one of a dialysate, a filtrate, a volume of a physiologically compatible priming solution, a volume of a physiologically compatible solution to provide a bolus of fluid to a subject receiving treatment, a volume of physiologically compatible solution to provide solution for return of blood from an extracorporeal flow path to a subject receiving treatment, a volume of solution returned to the common reservoir from an extracorporeal flow path when blood from a subject is introduced to the extracorporeal flow path, and combinations thereof;

the at least first pump for selectively metering in and/or metering out fluid from the controlled compliant flow path;

the at least first pump operable to control net fluid movement into and/or out of the controlled compliant flow path, wherein the at least first pump is operated by a controller applying an instantaneous rate of fluid removal to a control algorithm;

at least one conductivity sensor in the controlled compliant flow path;

the controller controlling a water pump, a salination pump, or combinations thereof, to control dialysate conductivity based on data received from the at least one conductivity sensor.

2. The system of claim 1 , wherein the controller applies the control algorithm to obtain a net volume of fluid added to and/or removed from a patient during therapy by an equation:

Σ i=0 n X i =patient fluid balance;

wherein n is a number of pumps fluidly connected to the controlled compliant flow path, i refers to a specific pump fluidly connected to the controlled compliant flow path, and X i is volumetric flow rate of a pump in either an influx or efflux direction; wherein is negative when pump i is operated in the efflux direction and positive when pump i is operated in an influx direction.

3. The system of claim 2 , wherein the number of pumps includes at least one selected from a water pump, an acid concentrate pump, a salination pump, a replacement fluid pump, and combinations thereof.

4. The system of claim 3 , the controller controlling applying an instantaneous rate of fluid removal to a control algorithm for each pump.

5. The system of claim 1 , wherein the controlled compliant flow path has a substantially inflexible volume.

6. The system of claim 1 , further comprising at least second pump that operates in a single direction to meter a controlled volume of a first fluid from the controlled compliant flow path and to return an equal volume of a second fluid to the controlled compliant flow path.

7. The system of claim 6 , wherein the second fluid contains a saline concentration different from the first fluid.

8. The system of claim 1 , wherein the extracorporeal flow path has a blood pump for circulating blood through the extracorporeal flow path, and a first valve and/or a second valve to selectively permit flow through a first conduit and a second conduit in fluid communication across either a dialyzer or hemofilter on the extracorporeal flow path.

9. The system of claim 8 , further comprising a first valve and/or a second valve, wherein at least the at least one pump coordinately operates with the first valve and/or a second valve to control fluid movement.

10. The system of claim 9 , wherein the at least one pump and the blood pump on the extracorporeal flow path coordinately operate with the first valve and/or second valve to control fluid movement.

11. The system of claim 1 , further comprising a microbial filter on the controlled compliant flow path wherein fluid passes through the microbial filter prior to crossing the dialyzer.

12. The system of claim 1 , further comprising a microbial filter on the controlled compliant flow path wherein fluid passes through the microbial filter prior to entering the extracorporeal flow path.

13. The system of claim 1 , wherein a volumetric flow rate of the water pump, salination pump, or combination thereof is included in the control algorithm.

14. The system of claim 13 , wherein the salination pump is in communication with a sodium chloride source, a buffer source, or combinations thereof.

15. The system of claim 14 , wherein the sodium chloride source is a sodium chloride cartridge that can increase a sodium chloride concentration of fluid passing through the sodium chloride cartridge and wherein the buffer source is a buffer source cartridge that can increase a buffer concentration of fluid passing through the buffer source cartridge.

16. The system of claim 14 , wherein the salination pump, sodium chloride source, and buffer source are positioned on a conditioning pathway, the conditioning pathway having an inlet and an outlet fluidly connected to the controlled compliant flow path.

17. The system of claim 1 , the controller determining a net fluid removal during an elapsed therapy time by integrating the instantaneous rate of fluid removal over a time course of therapy.

18. The system of claim 1 , the controller operating the at least one pump to accomplish a predetermined patient fluid balance at any time throughout a course of a therapy delivery session.

Assignments (3)
SECURITY INTEREST Recorded Dec 1, 2025
From: MOZARC MEDICAL US LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V, LP
Reel/Frame 073800/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2023
From: MEDTRONIC, INC.
To: MOZARC MEDICAL US LLC
Reel/Frame 063375/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2017
From: MEYER, THOMAS E.; LURA, DAVID B.; PUDIL, BRYANT J.; GERBER, MARTIN T.
To: MEDTRONIC, INC.
Reel/Frame 044380/0104 →
Cited By (3)
US 12,285,553 US 12,329,890 US 12,558,468